← Leaderboards
Zhiyu Dai
University Of Arizona
$7,862,593
Attributed
$8,988,478
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,988,478 · 6
By mechanism
R01$7,976,296 · 4
R00$747,000 · 1
K99$265,182 · 1
Top collaborators
- Michael B Fallon3 shared
Most similar at University Of Arizona
Same institution · by research overlap
- Timothy A Marlowe$5,077,422
- Francesca Polverino$4,920,719
Others in their field
Other Emerging Leaders on “Blood Vessels”
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Michael P Harms · Washington University$13,645,932
- Barbara Halina Braffett · George Washington University$13,172,222
- Alberto Rafael Ramos · University Of Miami School Of Medicine$11,170,423
Research focus
Blood VesselsSignal TransductionLungMortalityPulmonary Vascular ResistanceVascular RemodelingFailureCessation Of LifePathogenesisMediatingPrematureHeart HypertrophyLesionHypertensionTreatment StrategyProgressive DiseaseEffective TherapyPrimary Pulmonary HypertensionNovel Therapeutic InterventionPhenotypeMolecularReportingNew Therapeutic TargetCell Proliferation
Grant awards (18)
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome$751,151
R01 · FY2025 · HL
General Capillary to Arterial Endothelial Cell Transition in Pulmonary ArterialHypertension$723,817
R01 · FY2025 · HL · contact PI
Fatty acid-binding proteins sustain endothelial glycolysis and arterial programming in pulmonary arterial hypertension$569,497
R01 · FY2025 · HL · contact PI
Role of Endothelial SOX17 Deficiency in the Pathogenesis of Pulmonary Hypertension$437,404
R01 · FY2025 · HL · contact PI
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome$737,804
R01 · FY2024 · HL
General Capillary to Arterial Endothelial Cell Transition in Pulmonary ArterialHypertension$715,847
R01 · FY2024 · HL · contact PI
Fatty acid-binding proteins sustain endothelial glycolysis and arterial programming in pulmonary arterial hypertension$550,748
R01 · FY2024 · HL · contact PI
Role of Endothelial SOX17 Deficiency in the Pathogenesis of Pulmonary Hypertension$470,159
R01 · FY2024 · HL · contact PI
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome$762,815
R01 · FY2023 · HL
General Capillary to Arterial Endothelial Cell Transition in Pulmonary Arterial Hypertension$721,701
R01 · FY2023 · HL · contact PI
Fatty acid-binding proteins sustain endothelial glycolysis and arterial programming in pulmonary arterial hypertension$575,845
R01 · FY2023 · HL · contact PI
Role of Endothelial SOX17 Deficiency in the Pathogenesis of Pulmonary Hypertension$479,754
R01 · FY2023 · HL · contact PI
Role of Endothelial SOX17 Deficiency in the Pathogenesis of Pulmonary Hypertension$479,754
R01 · FY2022 · HL · contact PI
Role of Smooth Muscle Progenitor Cells in Obliterative Vascular Remodeling and PH$249,000
R00 · FY2021 · HL · contact PI
Role of Smooth Muscle Progenitor Cells in Obliterative Vascular Remodeling and PH$249,000
R00 · FY2020 · HL · contact PI
Role of Smooth Muscle Progenitor Cells in Obliterative Vascular Remodeling and PH$249,000
R00 · FY2019 · HL · contact PI
Role of Smooth Muscle Progenitor Cells in Obliterative Vascular Remodeling and PH$132,591
K99 · FY2018 · HL · contact PI
Role of Smooth Muscle Progenitor Cells in Obliterative Vascular Remodeling and PH$132,591
K99 · FY2017 · HL · contact PI